- 期刊
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study
延伸閱讀
- 高淑卿、林秀惠、許紋銘、劉榮宏、劉顯敏、陳博明（1991）。The Study of Immunoglobulin Heavy Chain and T-Cell Receptor β Chain Gene Rearrangement in Localized Orbital Lymphoid Tumor。中華民國眼科醫學會雜誌，30(2)，122-130。https://doi.org/10.30048/ACTASOS.199112.0064
- Hsieh, K. C., Wei, Y. F., Wang, C. Y., Ho, C. C., Yu, C. J., & Yang, P. C. (2008). Soluble Triggering Receptor Expressed on Myeloid Cells 1 (sTREM-1): A Possible Prognostic Factor for Patients with Malignancy. 胸腔醫學, 23(1), 1-7. https://doi.org/10.29806/TM.200802.0001
- Chan, W. (1995). Clonal rearrangement of T-cell receptor delta gene in hematological malignancies and applications in detection of minimal residualdisease [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200005783
- Hilbert, T., Steinhagen, F., Weisheit, C., Baumgarten, G., Hoeft, A., & Klaschik, S. (2015). Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1. Mediators of Inflammation, 2015(), 1016-1028-494. https://doi.org/10.1155/2015/948540
- Garvin, R. A. (2015). Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis. Journal of Lipids, 2015(), 37-41. https://doi.org/10.1155/2015/518654